RedHill Biopharma Ltd. (Nasdaq: RDHL), a specialty biopharmaceutical company primarily focused on proprietary drugs for gastrointestinal diseases, today announced the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE